Exosome Diagnostics | Personalized Precision Healthcare

Skip to main content

Shahky: the world's first point of care exosomal protein capture and analysis instrument NO UP-FRONT SAMPLE PREP IS REQUIRED • Ten microliters of biofluid input • Label free detection • Fully automated - Four minute run time • High sensitivity and specificity (100x more sensitive than ELISA) • Small desktop footprint (12" x 16" x 18")
• First and only molecular test to rule out high-grade prostate cancer • Completely non-invasive, non-DRE, urine-based liquid biopsy test • Easy-to-interpret results
A to D Program We can drive the regulatory pathway to commercialize your assay.

News & Events

RECENT NEWS

June 22, 2017

Exosome Diagnostics Presents Breakthrough Liquid Biopsy Technologies at BIO International Convention

May 31, 2017

Exosome Diagnostics Will Demonstrate the “Shahky” Point of Care Protein Detection Instrument at American Society for Clinical Oncology

April 26, 2017

American Medical Association (AMA) Grants Exosome Diagnostics a CPT PLA Specific to Its ExoDx® Prostate(IntelliScore) Test

February 6, 2017

Exosome Diagnostics Enters Agreement with Merck KGaA, Darmstadt, Germany

February 3, 2017

Exosome Diagnostics Announces Early Access Program for “Shahky” - Exosome Protein Interrogation Instrument

January 17, 2017

Exosome Diagnostics Obtains ISO 15189 for Its Munich Laboratory

January 4, 2017

Exosome Diagnostics Runs World’s First Point of Care Liquid Biopsy Instrument Within Leading Boston Hospital

Thursday, December 8, 2016

Exosome Diagnostics Announces the First Instrument for Point of Care Liquid Biopsy

Thursday, November 10, 2016

Exosome Diagnostics Unveils Novel Platform for Detection of Clinically Relevant Biomarkers

UPCOMING EVENTS

View more News and Events

Order Tests

Now available to Heathcare Providers for Clinical Use: The Industry’s First Exosome-Based Liquid Biopsy Tests

Order Here

The Industry’s First RNA-Based Liquid Biopsies

We are bringing the first exosome-based diagnostics to market. Learn more about our Laboratory Developed Tests, which will be analyzed in our CLIA-certified laboratory:

Follow Us on Twitter

Tweets by @ExosomeDx

© Exosome Diagnostics 2017